Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:
-- The first section of this topic is shown below --
- A recent national survey showed that 3.4% of all Americans identify themselves as lesbian, gay, bisexual, or transgender (LGBT). This may be an underestimation as men and women between 18 and 29 years old are more likely to identify themselves as LGBT at 4.6% and 8.3%, respectively.
- These percentages may not reflect all men who have sex with men (MSM). MSM may identify themselves as gay, bisexual, homosexual, or heterosexual. Current studies suggest 8% of the U.S. population engage in homosexual activity.
- The 2015 U.S. census reported a total of >410,000 households headed by male same-sex partners.
- LGBT individuals may hide their orientation in fear of stigma and discrimination, which may greatly affect their health.
- Health disparities exist among sexual minority groups (gay or lesbian and bisexual) and between sexual minority groups and heterosexuals; disparities are far reaching and include differences in health conditions, health behaviors, health care access, and health care utilization. Sexual minority groups tend to fare worse across all realms.
- Primary care specified toward MSM will be addressed here; lesbian and transgender health care will be discussed under their respective topic headings.
- It is recommended that MSM should receive hepatitis A and B immunizations (1)[A].
- Centers for Disease Control and Prevention (CDC) recommends testing for hepatitis B (1)[A].
- CDC does not recommend testing for hepatitis C unless individuals were born from 1945 through 1965, have HIV, or engage in risky behaviors (i.e., sharing needles or other equipment of injected drugs, unprotected sex, or multiple partners) (1)[A].
- Screening for hepatitis A infection is not recommended.
- Annual screening of HIV, syphilis, chlamydia, gonorrhea in individuals at risk